Furneri, G. (2016) “[Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]”, Farmeconomia. Health economics and therapeutic pathways, 17(2), pp. 67–80. doi: 10.7175/fe.v17i2.1251.